龙灯瑞迪制药WeChat
龙灯瑞迪制药
龙灯瑞迪制药 Language
龙灯瑞迪制药
EN CN
Product Name: Nilotinib Capsules
Product Name: Nilotinib Capsules
Products Name:Product Name: Nilotinib Capsules
Trade Name: 尼洛森®
Indications: This product is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase, and for pediatric patients aged 2 years and older with Ph+ CML in chronic phase. It is also indicated for the treatment of adult patients with Ph+ CML in chronic phase or accelerated phase who are resistant to or intolerant of prior therapy (including imatinib), and for pediatric patients aged 2 years and older with Ph+ CML in chronic phase.
Strength: 150 mg,200mg
Approval Number: National Drug Approval No. HJ20250067, National Drug Approval No. HJ20250068
View Package Insert
This content is only available to healthcare professionals. Non professionals can click 'Cancel'
Cancel
Confirm